Insider Trading activities of Biogen Inc. insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biogen Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biogen Inc. since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Biogen Inc. since 2005. The reporting company's ticker symbol is BIIB. The reporting company's CIK number is 875045.
The total value of stock buying since 2005 is $119,996,839.
The total value of stock sales since 2005 is $580,098,411.
The total value of stock option exercises since 2005 is $243,892,560.



Table 2. Detailed insider stock purchases, sales, and option exercises of Biogen Inc. insiders (BIIB) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-03-19 Mullen James C (CEO & President) Sale 334,221 59.97 20,043,901
2010-03-19 Mullen James C (CEO & President) Option Ex 334,221 50.44 16,858,107
2010-03-03 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Sale 4,255 57.33 243,956
2010-02-18 Hamm Robert A (Chief Operating Officer) Sale 6,581 56.16 369,556
2010-02-18 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Sale 6,552 56.16 367,934
2010-01-19 Maclean Michael F (SVP, Chief Accounting Officer) Sale 1,389 55.00 76,395
2009-12-24 Pangia Robert W (Director) Sale 15,000 52.15 782,220
2009-12-24 Pangia Robert W (Director) Option Ex 15,000 31.08 466,245
2009-12-16 Mullen James C (CEO & President) Sale 147,037 50.18 7,378,316
2009-11-04 Hamm Robert A (Chief Operating Officer) Sale 2,854 42.82 122,208
2009-11-01 Maclean Michael F (SVP, Chief Accounting Officer) Option Ex 1,000 .00 0
2009-09-29 Pangia Robert W (Director) Sale 15,000 52.00 780,000
2009-09-29 Pangia Robert W (Director) Option Ex 15,000 31.08 466,245
2009-06-24 Leaming Nancy (Director) Sale 820 48.52 39,788
2009-06-24 Ross Bruce (Director) Sale 1,700 48.53 82,497
2009-06-22 Hamm Robert A (Chief Operating Officer) Sale 3,194 50.26 160,520
2009-04-08 Pickett Cecil B (President, R & D) Sale 17,398 54.50 948,191
2009-02-19 Hamm Robert A (EVP, Pharma. Oper. & Tech.) Sale 3,412 50.90 173,674
2009-02-19 Dunn John Michael (EVP, New Ventures) Sale 3,208 50.90 163,300
2009-02-19 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Sale 6,606 50.93 336,443
2009-02-19 Hasler Hans Peter (Chief Operating Officer) Sale 11,693 50.94 595,653
2009-02-15 Alexander Susan H (EVP, General Counsel) Option Ex 2,666 .00 0
2009-02-11 Hamm Robert A (EVP, Pharma. Oper. & Tech.) Sale 3,670 50.76 186,281
2009-02-11 Dunn John Michael (EVP, New Ventures) Sale 2,258 50.81 114,728
2009-02-11 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Sale 5,400 50.76 274,082
2009-02-11 Hasler Hans Peter (Chief Operating Officer) Sale 5,135 50.77 260,698
2009-02-07 Mullen James C (CEO & President) Option Ex 26,666 .00 0
2009-02-06 Hamm Robert A (EVP, Pharma. Oper. & Tech.) Option Ex 5,466 .00 0
2009-02-06 Dunn John Michael (EVP, New Ventures) Option Ex 3,633 .00 0
2009-02-06 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Option Ex 8,000 .00 0
2009-02-06 Hasler Hans Peter (Chief Operating Officer) Option Ex 5,466 .00 0
2009-02-04 Pickett Cecil B (President, R & D) Sale 8,698 53.00 460,994
2009-01-30 Alexander Susan H (EVP, General Counsel) Option Ex 3,333 .00 0
2009-01-13 Leaming Nancy (Director) Sale 340 48.43 16,466
2008-11-06 Hamm Robert A (EVP, Pharma. Oper. & Tech.) Sale 2,855 44.70 127,612
2008-11-06 Hasler Hans Peter (Chief Operating Officer) Sale 845 44.31 37,445
2008-11-01 Maclean Michael F (SVP, Chief Accounting Officer) Option Ex 1,000 .00 0
2008-10-06 Maclean Michael F (SVP, Chief Accounting Officer) Sale 2,047 50.00 102,350
2008-09-26 Wiggins Mark C (EVP Corp. and Bus. Dev.) Sale 734 50.00 36,700
2008-09-19 Clancy Paul J (Executive VP and CFO) Sale 1,553 50.00 77,650
2008-08-08 Clancy Paul J (Executive VP and CFO) Sale 568 50.66 28,777
2008-07-31 Maclean Michael F (SVP, Chief Accounting Officer) Sale 1,875 72.77 136,443
2008-07-31 Maclean Michael F (SVP, Chief Accounting Officer) Option Ex 1,875 47.77 89,568
2008-07-25 Wiggins Mark C (EVP Corp. and Bus. Dev.) Option Ex 1,603 35.37 56,698
2008-07-23 Pickett Cecil B (President, R & D) Sale 5,054 72.00 363,888
2008-07-22 Maclean Michael F (SVP, Chief Accounting Officer) Sale 682 70.00 47,740
2008-07-22 Hamm Robert A (EVP, Pharma. Oper. & Tech.) Sale 156,086 70.00 10,926,020
2008-07-22 Hamm Robert A (EVP, Pharma. Oper. & Tech.) Option Ex 156,086 49.85 7,781,667
2008-07-22 Alexander Susan H (EVP, General Counsel) Sale 2,000 70.00 140,000
2008-07-22 Dunn John Michael (EVP, New Ventures) Sale 6,485 71.50 463,677
2008-07-22 Dunn John Michael (EVP, New Ventures) Option Ex 6,485 43.50 282,097
2008-07-22 Pickett Cecil B (President, R & D) Sale 23,108 70.00 1,617,560
2008-07-22 Hasler Hans Peter (EVP, Global Neurology, Int'l) Sale 12,950 69.31 897,564
2008-07-22 Hasler Hans Peter (EVP, Global Neurology, Int'l) Option Ex 12,950 49.31 638,564
2008-07-21 Dunn John Michael (EVP, New Ventures) Sale 6,485 67.50 437,737
2008-07-21 Dunn John Michael (EVP, New Ventures) Option Ex 6,485 4,350.00 28,209,750
2008-07-21 Sharp Philip A (Director) Sale 72,500 68.00 4,930,000
2008-07-21 Sharp Philip A (Director) Option Ex 72,500 35.42 2,567,950
2008-07-15 Wiggins Mark C (EVP Corp. and Bus. Dev.) Sale 6,250 64.00 400,000
2008-07-15 Wiggins Mark C (EVP Corp. and Bus. Dev.) Option Ex 6,250 59.39 371,187
2008-07-09 Hasnain Faheem (EVP, Oncology/Rheumatology SBU) Sale 36,837 62.13 2,288,830
2008-07-09 Hasnain Faheem (EVP, Oncology/Rheumatology SBU) Option Ex 30,175 46.77 1,411,435
2008-07-08 Alexander Susan H (EVP, General Counsel) Sale 8,599 60.00 515,940
2008-07-01 Clancy Paul J (CFO) Sale 4,208 56.01 235,677
2008-06-04 Ross Bruce (Director) Sale 1,840 61.62 113,384
2008-04-29 Glassberg Alan (Director) Sale 10,000 61.63 616,340
2008-04-29 Glassberg Alan (Director) Option Ex 10,000 31.08 310,830
2008-04-15 Hamm Robert A (EVP, Pharma. Oper. & Tech.) Sale 3,413 63.82 217,807
2008-04-15 Mullen James C (CEO & President) Sale 12,800 64.95 831,360
2008-04-15 Mullen James C (CEO & President) Option Ex 12,800 44.59 570,752
2008-04-14 Dunn John Michael (EVP, New Ventures) Sale 3,212 64.19 206,184
2008-04-14 Mullen James C (CEO & President) Sale 200 64.95 12,990
2008-04-14 Mullen James C (CEO & President) Option Ex 200 44.59 8,918
2008-04-11 Mullen James C (CEO & President) Sale 745,750 64.87 48,299,298
2008-04-11 Mullen James C (CEO & President) Option Ex 745,750 42.75 31,880,812
2008-04-08 Maclean Michael F (SVP, Chief Accounting Officer) Sale 2,214 64.39 142,552
2008-04-08 Hasnain Faheem (EVP, Oncology/Rheumatology SBU) Sale 6,425 64.47 414,187
2008-04-08 Pangia Robert W (Director) Sale 30,000 64.47 1,931,905
2008-04-08 Pangia Robert W (Director) Option Ex 30,000 7.79 233,730
2008-04-08 Sharp Philip A (Director) Sale 100,000 64.47 6,431,569
2008-04-08 Sharp Philip A (Director) Option Ex 100,000 35.42 3,542,000
2008-04-08 Hasler Hans Peter (EVP, Global Neurology, Int'l) Sale 28,493 64.34 1,831,296
2008-04-08 Hasler Hans Peter (EVP, Global Neurology, Int'l) Option Ex 17,094 43.87 749,913
2008-02-21 Clancy Paul J (CFO) Sale 2,183 60.29 131,621
2008-02-19 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Sale 3,344 63.18 211,283
2008-02-15 Alexander Susan H (EVP, General Counsel) Option Ex 2,667 .00 0
2008-02-12 Clancy Paul J (CFO) Sale 958 60.99 58,428
2008-02-12 Hamm Robert A (EVP, Pharma. Oper. & Tech.) Sale 3,679 60.91 224,080
2008-02-12 Dunn John Michael (EVP, New Ventures) Sale 2,267 60.94 138,146
2008-02-12 Wiggins Mark C (EVP Corp. and Bus. Dev.) Sale 4,286 60.95 261,223
2008-02-12 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Sale 15,134 61.00 922,642
2008-02-12 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Option Ex 9,725 49.31 479,539
2008-02-07 Mullen James C (CEO & President) Option Ex 26,667 .00 0
2008-02-06 Hasnain Faheem (EVP, Oncology/Rheumatology SBU) Option Ex 5,467 .00 0
2008-02-06 Hamm Robert A (EVP, Pharma. Oper. & Tech.) Option Ex 5,467 .00 0
2008-02-06 Dunn John Michael (EVP, New Ventures) Option Ex 3,633 .00 0
2008-02-06 Wiggins Mark C (EVP Corp. and Bus. Dev.) Sale 11,925 61.17 729,416
2008-02-06 Wiggins Mark C (EVP Corp. and Bus. Dev.) Option Ex 18,292 22.12 404,619
2008-02-06 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Sale 15,000 61.25 917,235
2008-02-06 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Option Ex 23,000 22.12 508,760
2008-02-06 Hasler Hans Peter (EVP, Global Neurology, Int'l) Option Ex 5,467 .00 0
2008-01-30 Alexander Susan H (EVP, General Counsel) Option Ex 3,333 .00 0
2007-12-31 Wiggins Mark C (EVP Corp. and Bus. Dev.) Sale 6,869 57.21 392,996
2007-12-31 Wiggins Mark C (EVP Corp. and Bus. Dev.) Option Ex 6,869 43.50 298,801
2007-12-31 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Sale 36,250 57.21 2,071,486
2007-12-31 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Option Ex 36,250 43.50 1,576,875
2007-11-01 Maclean Michael F (SVP, Chief Accounting Officer) Option Ex 1,000 .00 0
2007-10-15 Wiggins Mark C (EVP Corp. and Bus. Dev.) Sale 89,645 82.00 7,350,890
2007-10-15 Wiggins Mark C (EVP Corp. and Bus. Dev.) Option Ex 89,645 66.31 5,944,808
2007-10-15 Schenk Lynn (Director) Sale 63,000 82.00 5,166,000
2007-10-15 Schenk Lynn (Director) Option Ex 63,000 37.48 2,361,114
2007-10-15 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Sale 18,750 82.00 1,537,500
2007-10-15 Schneier Craig Eric (EVP, HR, Public Affairs & Comm) Option Ex 18,750 67.57 1,266,937
2007-10-15 Hasler Hans Peter (SVP, International) Sale 108,750 82.00 8,917,500
2007-10-15 Hasler Hans Peter (SVP, International) Option Ex 108,750 58.53 6,365,137
2007-10-15 Adelman Burt A (EVP, Portfolio Strategy) Sale 60,500 82.00 4,961,000
2007-10-15 Adelman Burt A (EVP, Portfolio Strategy) Option Ex 60,500 64.92 3,927,962
2007-10-15 Keller Thomas F (Director) Sale 10,350 82.00 848,700
2007-10-15 Keller Thomas F (Director) Option Ex 10,350 26.80 277,380
2007-09-06 Wiggins Mark C (EVP Corp. and Bus. Dev.) Sale 66,639 65.00 4,331,535
2007-09-06 Wiggins Mark C (EVP Corp. and Bus. Dev.) Option Ex 66,639 57.33 3,820,613
2007-08-30 Hasler Hans Peter (SVP, International) Sale 10,225 64.24 656,854
2007-08-30 Hasler Hans Peter (SVP, International) Option Ex 10,225 44.24 452,354
2007-08-30 Adelman Burt A (EVP, Portfolio Strategy) Sale 46,000 64.03 2,945,380
2007-08-30 Adelman Burt A (EVP, Portfolio Strategy) Option Ex 46,000 49.03 2,255,380
2007-08-27 Wiggins Mark C (EVP Corp. and Bus. Dev.) Sale 18,750 64.00 1,200,000
2007-08-27 Wiggins Mark C (EVP Corp. and Bus. Dev.) Option Ex 18,750 59.39 1,113,562
2007-08-27 Hasler Hans Peter (SVP, International) Sale 20,606 63.50 1,308,481
2007-08-27 Hasler Hans Peter (SVP, International) Option Ex 20,606 43.50 896,361
2007-08-27 Adelman Burt A (EVP, Portfolio Strategy) Sale 8,750 63.50 555,625
2007-08-27 Adelman Burt A (EVP, Portfolio Strategy) Option Ex 8,750 43.50 380,625
2007-08-24 Ross Bruce (Director) Sale 6,250 62.00 387,500
2007-08-24 Ross Bruce (Director) Option Ex 6,250 36.94 230,875
2007-08-24 Keller Thomas F (Director) Sale 6,900 62.00 427,800
2007-08-24 Keller Thomas F (Director) Option Ex 6,900 26.80 184,920
2007-08-17 Adelman Burt A (EVP, Portfolio Strategy) Sale 28,750 60.46 1,738,253
2007-08-17 Adelman Burt A (EVP, Portfolio Strategy) Option Ex 28,750 45.46 1,306,975
2007-07-26 Adelman Burt A (EVP, Portfolio Strategy) Sale 115,000 59.61 6,855,150
2007-07-26 Adelman Burt A (EVP, Portfolio Strategy) Option Ex 115,000 49.61 5,705,150
2007-07-25 Kowolenko Michael (SVP, Pharm Ops & Technology) Sale 20,507 58.00 1,189,406
2007-07-25 Kowolenko Michael (SVP, Pharm Ops & Technology) Option Ex 20,507 41.83 857,746
2007-07-25 Dunn John Michael (EVP, New Ventures) Sale 20,000 57.75 1,155,000
2007-07-25 Dunn John Michael (EVP, New Ventures) Option Ex 20,000 43.50 870,000
2007-07-25 Ross Bruce (Director) Sale 5,000 58.00 290,000
2007-07-25 Ross Bruce (Director) Option Ex 5,000 34.34 171,700
2007-07-25 Hasler Hans Peter (SVP, International) Sale 34,500 57.45 1,982,025
2007-07-25 Hasler Hans Peter (SVP, International) Option Ex 34,500 37.45 1,292,025
2007-07-25 Adelman Burt A (EVP, Portfolio Strategy) Sale 29,000 57.98 1,681,275
2007-07-25 Adelman Burt A (EVP, Portfolio Strategy) Option Ex 29,000 40.48 1,173,775
2007-07-24 Ross Bruce (Director) Sale 5,000 56.00 280,000

Insider trading activities including stock purchases, stock sales, and option exercises of BIIB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biogen Inc. (symbol BIIB, CIK number 875045) see the Securities and Exchange Commission (SEC) website.